Search


Current filters:
Start a new search
Add filters:

Use filters to refine the search results.


Results 51-60 of 141 (Search time: 0.003 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2012Editors' pick 2011Somogyi, A.; Loke, Y.; Ferro, A.; Lewis, L.; Cohen, A.; Ritter, J.
2010Editors' pick 2009Somogyi, A.; Loke, Y.; Ferro, A.; Lewis, L.; Cohen, A.; Ritter, J.
2008Flexible dosing of Tincture of Opium in the management of opioid withdrawal: pharmacokinetics and pharmacodynamicsSomogyi, A.; Larsen, M.; Abadi, R.; Jittiwutikarn, J.; Ali, R.; White, J.
2008Steady-state pharmacokinetics of the enantiomers of perhexiline in CYP2D6 poor and extensive metabolizers administered Rac-perhexilineDavies, B.; Herbert, M.; Coller, J.; Somogyi, A.; Milne, R.; Sallustio, B.
2009Editors' Report, December 2008Cohen, A.; Loke, Y.; Lewis, L.; Schachter, M.; Somogyi, A.; Ritter, J.
2012Editors' report, November 2011Somogyi, A.; Lewis, L.; Cohen, A.; Ferro, A.; Loke, Y.; Ritter, J.
2010(R)- and (S)-methadone and buprenorphine concentration ratios in maternal and umbilical cord plasma following chronic maintenance dosing in pregnancyGordon, A.; Lopatko, O.; Somogyi, A.; Foster, D.; White, J.
2012Methadone inhibits CYP2D6 and UGT2B7/2B4 in vivo: a study using codeine in methadone- and buprenorphine-maintained subjectsGelston, E.; Coller, J.; Lopatko, O.; James, H.; Schmidt, H.; White, J.; Somogyi, A.
2005The influence of CYP2D6 genotype on trough plasma perhexiline and cis-OH-perhexiline concentrations following a standard loading regimen in patients with myocardial ischaemiaDavies, B.; Coller, J.; James, H.; Somogyi, A.; Horowitz, J.; Sallustio, B.
2005Within- and between- subject variability in methadone pharmacokinetics and pharmacodynamics in methadone maintenance subjectsHanna, J.; Foster, D.; Salter, A.; Somogyi, A.; White, J.; Bochner, F.